Hem CME/CE Courses – Update

Hematology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

COVID-19 Infections and Hematologic Disturbances

COVID-19 Infections and Hematologic Disturbances

AMA PRA Category 1 Credit(s)TM
This education will provide physicians with the resources necessary to discuss treatment options with patients, payers and administrators to ensure that each stakeholder understands the importance of those options for the management of patients with hematologic malignancies and COVID-19.
RME Hot Seat: Weighing the Clinical Evidence on Treatment Strategies for Myeloma

Treatment Strategies for Myeloma | myCME

AMA PRA Category 1 Credit(s)TM
This RME Hot Seat provides a virtual Q&A with a panel of multiple myeloma (MM) experts who field a range of questions on MM patient care, covering such topics as the use of minimal residual disease (MRD)–driven maintenance approaches, immunotherapy, the use of belantamab mafodotin, cytogenetic risk status, and the value of three-drug and four-drug regimens.
Episode 1: Improving Diagnosis and Risk Stratification of Myelodysplastic Syndrome (MDS)

Episode 1: Improving Diagnosis and Risk Stratification of MDS

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
This is the first of 3 episodes in this Oncology Prime Time series which will address diagnosis, risk stratification, and the mechanisms and clinical applications of new and emerging agents in MDS.
Episode 2: Relating the Pathophysiology of MDS to the Mechanism of Action (MOA) of Novel Agents

Episode 2: Pathophysiology of MDS and the MOA of Novel Agents

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
This is the second of 3 episodes in this Oncology Prime Time series which will address diagnosis, risk stratification, and the mechanisms and clinical applications of new and emerging agents in MDS.
Biosimilars: Implications for Clinical Practice in Hematological Malignancies & Supportive Care

Biosimilars: Implications for Clinical Practice in Hematological Malignancies & Supportive Care | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
This webcast is intended to improve care of patients with hematological malignancies with biosimilars by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
AL Amyloidosis: Identifying Patients, Implementing Care

AL Amyloidosis: Identifying Patients, Implementing Care | myCME

AMA PRA Category 1 Credit(s)TM, ABIM MOC Points, CNE Contact Hour(s)
This activity features a roundtable discussion with a multidisciplinary panel of experts on the latest information on evidence-based diagnosis and treatment guidelines for patients with AL amyloidosis.
Changing Landscape of Treatment for Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
This webcast is intended to improve care of patients with acute lymphoblastic leukemia by accelerating adoption of new guidelines and evidence-based practice change.
Expert Perspectives on Rare Disease: Promoting Recognition, Diagnosis and Treatment of Cold Agglutinin Disease

Promoting Recognition, Diagnosis and Treatment of CAD

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
In this activity, Catherine M. Broome, MD, and Alexander Röth, MD, provide an understanding of the pathogenesis of Cold Agglutinin Disease (CAD) caused by cold-reacting IgM autoantibodies and reveal common clinical features.

Click for More Hematology Courses

Next hm-section-front in CME